The bipartisan agreement includes $10 billion in to make it easier for veterans who can’t get prompt appointments with Veterans Affairs doctors to obtain outside care; $5 billion to hire doctors, nurses and other medical staff; and about $1.5 billion to lease 27 new clinics across the country.
With federal research funding declining, drug companies are taking a larger role funding the medical research happening at IU and universities around the country. That’s not the same thing as paying to market drugs, but it’s hardly without controversy.
Results of a Roche clinical trial mirror those produced by an experimental Lilly drug two years ago. Lilly executives say that validates their approach in the multi-billion-dollar race to market the first drug to reverse Alzheimer’s.
Federal researchers predict that about 4 million people, including dependents, could be hit with fines by 2016.
If this week’s D.C. appeals court ruling stands up—declaring the Obamacare tax subsidies illegal in Indiana and most other states—Gov. Mike Pence could face significant pressure, even from traditional Republican supporters, to keep the tax credits flowing.
There is truth in the old adage that all work and no play makes Jack a dull boy, but it also makes Jack unhappier, less healthy and not as effective of an employee.
Indianapolis-based Lilly and Co. lost 17 percent of its revenue during the second quarter as U.S. patents expired on its bestselling drugs Cymbalta and Evista.
President Barack Obama's health care law is snarled in another big legal battle, with two federal appeals courts issuing contradictory rulings on a key financing issue within hours of each other Tuesday.
The Obamacare tax credits that brought nearly $400 million to Indiana this year to help Hoosiers buy health insurance could go away after a federal appeals court ruled Tuesday they were illegal.
One of the open secrets in health care is that hospitals are paid substantially more than independently owned health care facilities for the same procedures. But those higher fees are facing unprecedented pressure.
Obamacare could, according to some health insurance experts, cause most small businesses to end their group health plans. Now a new venture-backed company opening up shop in Indiana is trying to make that prediction a reality.
A health care system that includes a Terre Haute hospital says it will cut 150 jobs by the end of the year.
All of sudden, Hoosiers are buying less health care. Is that because we’ve kicked the habit, sobered up and found religion? Or is it the Great Recession hangover that will pass, eventually, so we can all get back to the party?
Advances in non-invasive surgeries, changes in health care financing and now increasingly price-sensitive patients accelerate what has been a 40-year decline in the number of patients spending the night in hospitals.
With federal health research funding in decline, Indianapolis-based Regenstrief Institute Inc. wants to make up the difference by serving pharmaceutical companies, medical device makers, health insurers and hospital systems.
Indianapolis ranked fifth highest among the nation’s largest cities for the most positive reviews of physicians. On a five-point Patient Happiness Index, the average review by patients scored Indianapolis physicians at a 4.05. San Francisco physicians topped the list.
To cut medical costs and diagnose minor ailments, WellPoint Inc. and Aetna Inc., among other health insurers, are letting millions of patients get seen online first.
Indiana physicians and research organizations reaped more than $25 million in payments from 15 pharmaceutical firms in 2012, according to the most recent data made available by the not-for-profit group ProPublica. Lilly was the biggest spender and the IU medical school was the biggest recipient.
Indianapolis-based WellPoint saw its shares close July 9 at $110.87 per share, compared with less than $85 just five months ago.
In a wide-ranging interview, WellPoint Inc. CEO Joseph Swedish says adapting to technology is a top priority as he leads the nation's second largest health insurer.
